Implantation or Injectable Dosage Form New Animal Drugs; Tylosin

• Date: November 06, 2009
• Source: www.fda.gov

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health. The supplemental NADA provides for changing scientific nomenclature for a bovine pathogen on labeling for tylosin injectable solution

Effective Date: This rule is effective March 19,2009

Click here to download the file